{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:42:10Z","timestamp":1761129730524,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Overactive bladder syndrome (OAB) is defined as urinary urgency, usually with urinary frequency and nocturia, with or without urge urinary incontinence. The prevalence of OAB in adult women ranges between 11% and 42%, is particularly common in elderly people, and can overlap with the genitourinary syndrome of menopause (GSM). There is a wide approach to the treatment of symptoms, often in a stepwise fashion, including lifestyle changes, bladder retraining and pelvic floor muscle rehabilitation, drug therapy, intra-vesical botulinum toxin injections or neuromodulation. Recently, vaginal laser therapy has been proposed as an emerging minimal invasive effective treatment option for women with OAB. We explore this further.<\/jats:p>","DOI":"10.1007\/s00192-020-04319-z","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T08:04:16Z","timestamp":1589270656000},"page":"1515-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaginal laser for overactive bladder syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Ioannis","family":"Charalampous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visha K.","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Digesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"10","key":"4319_CR1","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00192-019-04022-8","volume":"30","author":"FC Hsu","year":"2019","unstructured":"Hsu FC, Weeks CE, Selph SS, Blazina I, Holmes RS, McDonagh MS. Updating the evidence on drugs to treat overactive bladder: a systematic review. Int Urogynecol J. 2019;30(10):1603\u201317. https:\/\/doi.org\/10.1007\/s00192-019-04022-8.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"4319_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00192-018-3844-7","volume":"30","author":"AA Bhide","year":"2019","unstructured":"Bhide AA, Khullar V, Swift S, Digesu GA. The use of laser in urogynaecology. Int Urogynecol J. 2019;30(5):683\u201392. https:\/\/doi.org\/10.1007\/s00192-018-3844-7.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"4319_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00192-018-3830-0","volume":"30","author":"SA Shobeiri","year":"2019","unstructured":"Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA Research and Development Committee. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J. 2019;30(3):371\u20136. https:\/\/doi.org\/10.1007\/s00192-018-3830-0.","journal-title":"Int Urogynecol J"},{"issue":"11","key":"4319_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00192-019-04051-3","volume":"30","author":"A Tranoulis","year":"2019","unstructured":"Tranoulis A, Georgiou D, Michala L. Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype? Int Urogynecol J. 2019;30(11):1879\u201386. https:\/\/doi.org\/10.1007\/s00192-019-04051-3.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"4319_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00192-018-3812-2","volume":"30","author":"B Garcia","year":"2019","unstructured":"Garcia B, Pardo J. Academic cosmetic gynecology and energy-based therapies: ambiguities, explorations, and FDA advisories. Int Urogynecol J. 2019;30(1):1\u20132. https:\/\/doi.org\/10.1007\/s00192-018-3812-2.","journal-title":"Int Urogynecol J"},{"issue":"10","key":"4319_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00192-019-04204-4","volume":"30","author":"H Dabaja","year":"2019","unstructured":"Dabaja H, Lauterbach R, Matanes E, Gruenwald I, Lowenstein L. The safety and efficacy of CO2 laser in the treatment of stress urinary incontinence. Int Urogynecol J 2019;30(10):1603\u201317. https:\/\/doi.org\/10.1007\/s00192-019-04204-4.","journal-title":"Int Urogynecol J"},{"key":"4319_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-019-04148-9","author":"A Kuszka","year":"2019","unstructured":"Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data. Int Urogynecol J 2019. https:\/\/doi.org\/10.1007\/s00192-019-04148-9.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"4319_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00192-017-3352-1","volume":"29","author":"P Gonz\u00e1lez Isaza","year":"2018","unstructured":"Gonz\u00e1lez Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018;29(2):211\u20135. https:\/\/doi.org\/10.1007\/s00192-017-3352-1.","journal-title":"Int Urogynecol J"},{"issue":"12","key":"4319_CR9","first-page":"2491","volume":"20","author":"A Perino","year":"2016","unstructured":"Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20(12):2491\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4319_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23220","author":"LB Aguiar","year":"2020","unstructured":"Aguiar LB, Politano CA, Costa-Paiva L, Juliato CRT. Efficacy of fractional CO2 laser, Promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial. Lasers Surg Med 2020. https:\/\/doi.org\/10.1002\/lsm.23220.","journal-title":"Lasers Surg Med"},{"issue":"6","key":"4319_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.tjog.2017.10.020","volume":"56","author":"YH Lin","year":"2017","unstructured":"Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol. 2017;56(6):815\u201320. https:\/\/doi.org\/10.1016\/j.tjog.2017.10.020.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"11","key":"4319_CR12","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00345-019-02644-7","volume":"37","author":"N Okui","year":"2019","unstructured":"Okui N. Efficacy and safety of non-ablative vaginal erbium: YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and \u03b23-adrenoceptor agonists. World J Urol. 2019;37(11):2459\u201366. https:\/\/doi.org\/10.1007\/s00345-019-02644-7.","journal-title":"World J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04319-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:29:53Z","timestamp":1620775793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04319-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4319"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04319-z","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"type":"print","value":"0937-3462"},{"type":"electronic","value":"1433-3023"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}